Nicholas Focil is the CEO at Fomat Medical Research, a network of research centers based in Oxnard, California. Nicholas graduated from California with a Biochemistry and MBA degree. During his undergrad days, he spent his extra time in a research lab working with a nominated noble laureate performing investigator-initiated studies, and publishing weekly articles for a spectrum of publications. Was then recruited by Medtronic MiniMed Diabetes division to do pre-pivotal trials. Thereafter, was recruited for the purpose of managing and expanding Diverse Research Solutions. He then spearheaded the spinoff and expansion of FORMAT Medical Research through both the U.S. and Latin America with current operations in the USA (California and Florida), Ecuador, Colombia, and Peru. With well over a decade of research experience, Nicholas, as the CEO of Fomat Medical Research and proud founding partner of hyper core International, continues to innovate and pioneer clinical research in both regions.
Nicholas Focil, CEO at Fomat Medical Research
Subscribe to Our Newsletter
Get the latest on clinical trials in Latin America — regulatory updates, market access strategies & industry trends. Delivered straight to your inbox.
Email has been submitted.
Recent Episodes
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- Leonara vidal, Global Clinical Affairs Lead at Gentell
- Gerardo Noriega, Presiden & CEO at PercAssist, Inc
- Matt DeNardo, Chief Product Officer at Axoft
- Daniel Chen, Founder and CEO at Synthetic Design Lab
- Shareef Mahdavi, Founder at PX Movement
- See all →